Literature DB >> 9258282

Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.

H Ono1, A Sakamoto, T Eguchi, N Fujita, S Nomura, H Ueda, N Sakura, K Ueda.   

Abstract

Plasma total homocysteine (tHcy) and serum folate (FA) concentrations were measured in 130 epileptic patients taking anticonvulsant drugs. A significant inverse correlation was found between FA and tHcy. This was greater in the older group (> or = 15 years) than in the younger group (1 to 14 years). There were four FA-deficient patients (FA concentration < 3 ng/mL regardless of symptoms), including three patients in the older group and one in the younger group. All FA-deficient patients had received long-term treatment (> 7 years) with multiple anticonvulsants. Their tHcy levels were higher than the 90th percentile of those in control subjects. Two patients showed extremely high levels of tHcy (57.9 and 29.1 mumol/L) and subnormal plasma methionine levels. After FA therapy, their tHcy decreased to levels the same as or less than those of control subjects and FA increased to above the normal range. Based on these findings, we conclude that measuring FA and tHcy concentrations may be useful for preventing thrombosis due to hyperhomocysteinemia in epileptic patients taking anticonvulsants, particularly those who receive long-term treatment with multiple agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9258282     DOI: 10.1016/s0026-0495(97)90087-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

Review 1.  Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.

Authors:  Bruce Hermann; Michael Seidenberg; Mark Sager; Cynthia Carlsson; Barry Gidal; Raj Sheth; Paul Rutecki; Sanjay Asthana
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

2.  Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia.

Authors:  D Caccamo; S Condello; G Gorgone; G Crisafulli; V Belcastro; S Gennaro; P Striano; F Pisani; R Ientile
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 3.  Drugs affecting homocysteine metabolism: impact on cardiovascular risk.

Authors:  Cyrus Desouza; Mary Keebler; Dennis B McNamara; Vivian Fonseca
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Assessment of asymmetric dimethylarginine and homocysteine in epileptic children receiving antiepileptic drugs.

Authors:  Asmaa A Mahmoud; Hesham M Aboelghar; Sabry Moawad Abdelmageed; Heba M Abdallah; Mohamed I Garib; Nahla M S Abd El Hady
Journal:  Pediatr Res       Date:  2022-06-10       Impact factor: 3.756

5.  Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels.

Authors:  Stéphanie Badiou; Hélène Breton; Hélène Peyriere; Virginie Charasson; Arielle Crespel; Philippe Gelisse; Jean-Paul Cristol; Dominique Hillaire-Buys
Journal:  Eur J Clin Pharmacol       Date:  2007-10-31       Impact factor: 2.953

6.  Antiepileptic Drugs and Homocysteine Levels.

Authors:  Andres M. Kanner
Journal:  Epilepsy Curr       Date:  2002-03       Impact factor: 7.872

7.  Effects of Common Anti-epileptic Drugs on the Serum Levels of Homocysteine and Folic Acid.

Authors:  Zamzam Paknahad; Ahmad Chitsaz; Akbar Hasan Zadeh; Elham Sheklabadi
Journal:  Int J Prev Med       Date:  2012-03

8.  Folic Acid and Epilepsy.

Authors:  Martha J. Morrell
Journal:  Epilepsy Curr       Date:  2002-03       Impact factor: 7.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.